Oyster Point Pharma Profit Margin

The latest profit margin for OYST is -964.93% as of September 2022. That compares with -450.47% in the prior-year period — down 114.2% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Oyster Point Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, OYST's profit margin moved from -450.47% to -964.93% — a 114.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Oyster Point Pharma's valuation or profitability profile.

Against Healthcare companies, OYST currently prints -964.93% for profit margin, while the sector average sits near 9.48%. That is roughly 10277.6% below the sector mean. Large gaps often invite a closer look at Oyster Point Pharma's growth, margins, and balance sheet.

Profit Margin shows how effectively Oyster Point Pharma converts resources into returns. At -964.93%, OYST may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -450.47% in the prior-year period — down 114.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting OYST's profit margin (-964.93%), review year-over-year change from -450.47%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.